A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction

American Heart Journal

Volumn 148, Issue 3, 2004, Pages 518-523

  Atisha, Dunya ^a   Bhalla, Meenakshi A ^a   Morrison, L Katherine ^a   Felicio, Leda ^a   Clopton, Paul ^a   Gardetto, Nancy ^a   Kazanegra, Radmila ^a   Chiu, Albert ^a   Maisel, Alan S ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; SCREENING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4644316861     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.03.014     Document Type: Article

References (20)

1. Devereux R.B., Liebson P.R., Horan M.J. Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension. 9:1987;II97-104
2. Talreja D., Gruver C., Sklenar J., et al. Efficient utilization of echocardiography for the assessment of left ventricular systolic function. Am Heart J. 139:2000;394-398
3. Senni M., Rodeheffer R.J., Tribouilloy C.M., et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol. 33:1999;164-170
4. Maeda K., Tsutamoto T., Wada A., et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 135:1998;825-832
5. Harrison A., Morrison L.K., Krishnaswamy P., et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 39:2002;131-138
6. Maisel A.S., Koon J., Krishnaswamy P., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 141:2001;367-374
7. Krishnaswamy P., Lubein E., Clopton P., et al. Utility of B-type natriuretic peptide (BNP) in elucidating left ventricular dysfunction (systolic and diastolic) in patients with and without symptoms of congestive heart failure at a Veterans Hospital. Am J Med. 111:2001;274-279
8. Lubien E, DeMaria A, Krishnaswamy, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601
9. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 351:1998;9-13
10. Suzuki T., Yamaoki K., Nakajima O., et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels. Jpn Heart J. 41:2000;205-214
11. Nielsen O.W., McDonagh T.A., Robb S.D., et al. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol. 41:2003;113-120
12. Feigenbaum H. Echocardiography. 6th ed:1999;Lea and Febiger, Philadelphia
13. Schiller N.B., Acquatella H., Ports T.A., et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation. 60:1979;547
14. Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting. J Am Coll Cardiol. 37:2001;379-385
15. Cheng V., Kazanegra R., Garcia A., et al. A rapid bedside test for peptide (BNP) predicts treatment outcomes in patients admitted for decompensated heart failure. J Am Coll Cardiol. 37:2001;386-391
16. Remes J., Miettinen H., Reunanen A., et al. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 12:1991;315-321
17. Fox K.F., Cowie M.R., Wood D.A. The etiological importance of coronary artery disease in new cases of heart failure. Eur Heart J. 22:2001;228-236
18. Maisel A.S., Koon J., Hope J., et al. A rapid bedside test for brain natriuretic peptide accurately predicts cardiac function in patients referred for echocardiography. Am Heart J. 141:2001;374-379
19. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1349-1353
20. Mundy B.J., McCord J., Hudson M.P., et al. B-natriuretic peptide levels are inversely related to body mass index in patients with heart failure [abstract]. J Am Coll Cardiol. 41:2003;158A